North America Single-Use Bioreactors Market (2026-2031)
The North America Single-Use Bioreactors Market was valued at $2062.3 Million in 2026 and projected to reach to $3694.4 Million by 2031, representing a compound annual growth rate of 12.4%. North America's single-use bioreactors market is poised for sustained expansion through 2031, supported by increasing demand for flexible, cost-effective manufacturing solutions in biopharmaceutical production.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America Single-Use Bioreactors Market Trends and Insights
- This 12.4% compound annual growth rate reflects North America's leadership in biopharmaceutical manufacturing and cell therapy development.
- North America's advanced regulatory framework, concentration of biotech companies, and investment in manufacturing infrastructure are driving adoption of single-use bioreactor technologies across the region. The North America market benefits from strong demand in vaccine production, monoclonal antibody manufacturing, and regenerative medicine applications.
- North America's pharmaceutical and biotechnology sectors are increasingly transitioning from traditional stainless-steel systems to single-use platforms, driven by operational flexibility and reduced contamination risks.
- Between 2026 and 2031, North America is expected to maintain its position as a key growth market, supported by ongoing innovation and capital investment in biomanufacturing capacity..
Key Market Statistics
- CAGR (2026-2031) 12.4% CAGR
- Market Size, 2026 ~USD 2062.3 Million
- Forecast, 2031 ~USD 3694.4 Million
- Geography North America
North America Single-Use Bioreactors Market Overview
Market Leadership Position :
North America commands the largest share of the global single-use bioreactors market, driven by the region's concentration of leading biopharmaceutical manufacturers and advanced manufacturing infrastructure.
Robust Growth Trajectory :
The North American market is projected to grow from $2,062.3 million in 2026 to $3,694.4 million by 2031, representing a strong 12.4% CAGR that outpaces the global average of 12%.
Cell Therapy Innovation Hub :
North America's leadership in cell and gene therapy development is accelerating single-use bioreactor adoption, with major investments from biotech companies and research institutions driving market expansion.
Regulatory Excellence & Investment :
The region's advanced regulatory framework, FDA oversight, and substantial venture capital funding create an optimal environment for single-use bioreactor technology adoption and innovation.
North America Single-Use Bioreactors Market Dynamics
- The region's dominance in cell therapy and personalized medicine development continues to drive adoption of single-use technologies, which offer reduced contamination risk and faster time-to-market advantages. Key growth drivers include rising investments in biotech infrastructure, growing prevalence of chronic diseases requiring advanced therapeutics, and regulatory support for innovative manufacturing approaches.
- The US market, representing the largest segment, will continue to lead regional growth, while Canada's emerging biotech sector presents additional expansion opportunities for market participants..
Market Ecosystem
SINGLE-USE BIOREACTORS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Deployed six 4,000 L ABEC CSR single-use bioreactors at its Pune facility to support large-scale manufacturing of Novavax’s NVX-CoV2373 vaccine. | Established 24,000 L of single-use production capacity | The 4,000 L systems doubled productivity per unit of floor space, supported accelerated facility startup, and reduced manufacturing cost per dose. |
 |
Implemented Cytiva Xcellerex Disposable Reactors (XDR) for mAb and bispecific antibody production. | Demonstrated that XDR bioreactors can be used effectively for antibody production | The system met all benchmarks for viable cell density, viability, integral viable cell count (IVC), and titer | The real-time CO2 monitoring proved effective, allowing maintenance of optimal culture conditions. |
 |
Implemented Sartorius Ambr and BIOSTAT STR platforms, ranging from process-development systems to 500 L and 2,000 L single-use bioreactors, at its San Diego biologics facility. | Enabled consistent scale-up from development to GMP production, improved process-data continuity, and supported seamless technology transfer for Phase I through commercial biologics manufacturing. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- North America's single-use bioreactors market is valued at $2,062.3 million in 2026 and will reach $3,694.4 million by 2031, representing a 12.4% CAGR.
- North America leads global adoption of single-use bioreactor technology due to advanced regulatory infrastructure and high concentration of biopharmaceutical manufacturers.
- North America's market growth is driven by increasing demand for flexible, contamination-resistant manufacturing solutions in vaccine and cell therapy production.
- North America's biotech sector's shift from traditional stainless-steel to single-use platforms will accelerate market expansion through 2031.
Single-Use Bioreactors Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | CELL & GENE THERAPY (Molecule Type) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 12% from 2026 to 2031 |
| Largest Segment | BIOPRODUCTION (Application) |
| Market Size Base Year (Billions) | ~USD 5.44 (2026) |
| Revenue Forecast (Billions) | ~USD 9.58 (2031) |
| Segments Covered | Product, Scale Range, Type, Molecule Type, Cell Type, Application, Process Mode, End User |
North America Single-Use Bioreactors Market Report Segmentation
8 segment dimensions are covered across the global market.
By Product
- Other Products
- Single-Use Assemblies
- Single-Use Bags
- Single-Use Bioreactor Systems
By Scale Range
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- <=10 L Bioreactors
By Type
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 2D Single-Use Bags
- 3D Single-Use Bags
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- Bubble-Column Single-Use Bioreactors
- Fixed-Bed Single-Use Bioreactors
- Other Single-Use Bioreactors
- Stirred-Tank Single-Use Bioreactors
- Wave-Induced Single-Use Bioreactors
- <=10 L Bioreactors
By Molecule Type
- Cell & Gene Therapy
- Monoclonal Antibodies
- Therapeutic Proteins & Peptides
- Vaccines
By Cell Type
- Bacterial Cells
- Mammalian Cells
- Other Cells
- Yeast Cells
By Application
- Bioproduction
- Process Development
- Research & Development
By Process Mode
- Batch Process Mode
- Feb-Batch Process Mode
- Fed-Batch Process Mode
- Perfusion/Continuous Process Mode
By End User
- Academic & Research Institutes
- Cros & Cmos
- Pharmaceutical & Biotechnology Companies
Target Audience
- Biopharmaceutical Manufacturers : North American pharma and biotech companies need regional market data to optimize manufacturing strategies, evaluate single-use technology investments, and benchmark against competitors in the world's largest bioreactor market.
- Bioreactor Equipment Suppliers : Equipment manufacturers and technology providers require detailed North American market insights to identify growth opportunities, understand customer needs, and develop region-specific product strategies.
- Investment & Private Equity Firms : Investors evaluating biotech and manufacturing opportunities need comprehensive North American market analysis to assess portfolio companies, identify acquisition targets, and evaluate sector growth potential.
- Contract Manufacturing Organizations (CMOs) : CMOs operating in North America require market forecasts and adoption trends to plan capacity expansion, invest in single-use technology infrastructure, and secure client contracts.
- Regulatory & Compliance Consultants : Consultants advising biotech clients need North American market context to guide manufacturing decisions, regulatory strategy, and technology adoption aligned with regional FDA requirements and industry standards.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 1522.8 Million |
| Canada | USD 376.8 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Dominance Insights : Gain comprehensive understanding of North America's leadership position in the global single-use bioreactors market, including competitive dynamics and market share distribution across the US and Canada.
- Accurate Growth Projections : Access detailed forecasts showing North America's market expansion from $2,062.3M to $3,694.4M by 2031, enabling precise business planning and investment decisions for the region.
- Country-Level Market Segmentation : Understand distinct market opportunities in the US ($1,522.8M) and Canada ($376.8M), with tailored insights for each country's unique regulatory environment and biotech ecosystem.
- Technology Adoption Trends : Identify key drivers of single-use bioreactor adoption in North America's cell therapy and biopharmaceutical sectors, including regulatory influences and manufacturing innovation patterns.
- Strategic Investment Guidance : Make informed decisions on market entry, expansion, and partnership opportunities in North America's high-growth bioreactor segment with data-driven regional analysis.
Frequently asked questions
What is the current market size of single-use bioreactors in North America?
North America's single-use bioreactors market was valued at $2,062.3 million in 2026 and is projected to grow to $3,694.4 million by 2031.
What is the expected growth rate for North America's single-use bioreactors market?
North America's single-use bioreactors market is expected to grow at a compound annual growth rate (CAGR) of 12.4% from 2026 to 2031.
Why is North America a leading market for single-use bioreactors?
North America leads due to its advanced regulatory environment, high concentration of biopharmaceutical companies, significant R&D investment, and established manufacturing infrastructure supporting biopharmaceutical production.
What applications are driving growth in North America's single-use bioreactors market?
Key applications include vaccine production, monoclonal antibody manufacturing, cell therapy development, and regenerative medicine, all experiencing increased demand in North America.
How is North America's market positioned relative to global single-use bioreactors trends?
North America's 12.4% CAGR slightly exceeds the global average of 12%, reflecting the region's accelerated adoption of single-use technologies and strong biopharmaceutical sector growth.
RESEARCH METHODOLOGY
This research study relied extensively on secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-use bioreactors market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at major market players, and industry consultants, to gather and validate critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioreactors market. The secondary sources used for this study include National Institutes of Health (NIH), National Institute for Bioprocessing Research and Training (NIBRT), Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), Biotechnology Innovation Organization (BIO), BioProcess International, BioPharm International, BioPlan Associates, Organisation for Economic Co-operation and Development (OECD) R&D Expenditure, National Center for Biotechnology Information (NCBI), World Health Organization (WHO), Food and Drug Administration (FDA); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioreactors market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Single-use bioreactors (SUBs) or disposable bioreactors consist of a disposable bag instead of a typical stainless steel or glass culture vessel. SUBs are based on single-use technology, which uses disposable components to manufacture biopharmaceutical products. The key benefits of single-use bioreactors include reduced risk of cross-contamination, lower capital and operational costs, faster turnaround times, and greater manufacturing flexibility. These advantages make single-use systems particularly attractive for producing biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.
The report presents the market size for single-use bioreactor systems, single-use bags, single-use assemblies, and other products that can be incorporated with single-use bioreactors.
Key Stakeholders
- Manufacturers of single-use bioreactors and associated products
- Distributors of single-use bioreactors and related products
- Pharmaceutical and biotechnology companies
- Contract manufacturing companies (CMOs)
- Contract research organizations (CROs)
- Academic and research institutes
- Life sciences companies
- Market research and consulting firms
- Venture capitalists and investors
- Government organizations
- Medical institutes and universities
- Private research firms
Report Objectives
- To define, describe, and forecast the global single-use bioreactors market based on product, type, cell type, process mode, molecule type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall single-use bioreactors market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the single-use bioreactors market
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the single-use bioreactors market
Available customizations:
Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment- Product Matrix, which gives a detailed comparison of the product portfolios of the top four companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- A further breakdown of the Rest of Europe single-use bioreactors market, by country
- A further breakdown of the Rest of Asia Pacific single-use bioreactors market, by country
- A further breakdown of the Rest of Latin America single-use bioreactors market, by country
Get the Full Single-Use Bioreactors Market Report
Full forecast, segment splits, and company analysis for all Single-Use Bioreactors Market.
- Canada Single-Use Bioreactors Market
- US Single-Use Bioreactors Market
- Germany Single-Use Bioreactors Market
- UK Single-Use Bioreactors Market
- France Single-Use Bioreactors Market
- Italy Single-Use Bioreactors Market
- Spain Single-Use Bioreactors Market
- China Single-Use Bioreactors Market
- South Korea Single-Use Bioreactors Market
- Japan Single-Use Bioreactors Market
- India Single-Use Bioreactors Market
- Australia Single-Use Bioreactors Market
- Brazil Single-Use Bioreactors Market
- Mexico Single-Use Bioreactors Market
- Rest Of Europe Single-Use Bioreactors Market
- Rest Of Asia Pacific Single-Use Bioreactors Market
- Rest Of Latin America Single-Use Bioreactors Market
- Rest Of GCC Countries Single-Use Bioreactors Market
- Saudi Arabia (Ksa) Single-Use Bioreactors Market
- United Arab Emirates (UAE) Single-Use Bioreactors Market
- GCC Countries Single-Use Bioreactors Market
- Rest Of Middle East Single-Use Bioreactors Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
